• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

33种新型AVPR2突变报告及117个X连锁肾性尿崩症家系分析

Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.

作者信息

Arthus Marie-Françoise, Lonergan Michèle, Crumley M Joyce, Naumova Anna K, Morin Denis, DE Marco Luiz A, Kaplan Bernard S, Robertson Gary L, Sasaki Sei, Morgan Kenneth, Bichet Daniel G, Fujiwara T Mary

机构信息

Department of Medicine, Université de Montréal and Research Centre, Hôpital du Sacré-Coeur de Montréal, Montreal, Canada.

Montreal General Hospital Research Institute, Montreal, Canada.

出版信息

J Am Soc Nephrol. 2000 Jun;11(6):1044-1054. doi: 10.1681/ASN.V1161044.

DOI:10.1681/ASN.V1161044
PMID:10820168
Abstract

X-linked nephrogenic diabetes insipidus (NDI) is a rare disease caused by mutations in the arginine vasopressin receptor 2 gene (AVPR2). Thirty-three novel AVPR2 mutations were identified in 62 families that were not included in our previous studies. This study describes the diversity of mutations observed in a total of 117 families, the number of affected people at the time of diagnosis, skewed X chromosome inactivation in severely affected females, the inferred parental origin of de novo mutations, and it provides estimates of incidence. Among 117 families, there were 82 different putative disease-causing mutations. Based on haplotype analysis, it can be inferred that when the same AVPR2 mutation is identified in different families that were not known to be related, the mutations most likely arose independently. More than half of the families had only one affected male; two families presented with a severely affected female and no family history of NDI. A de novo mutation arose during oogenesis in the mother in 20% of isolated cases. The estimate of about 8.8 per million male live births of the incidence of X-linked NDI in the province of Quebec, Canada may be representative of the general population except in Nova Scotia and New Brunswick, where the incidence is more than six times higher. Documentation of the diversity of mutations will assist in revealing the full spectrum of clinical variation. Discussion of genetic and population genetic aspects of X-linked NDI may contribute to early diagnosis and treatment.

摘要

X连锁肾性尿崩症(NDI)是一种由精氨酸加压素受体2基因(AVPR2)突变引起的罕见疾病。在我们之前的研究未纳入的62个家庭中鉴定出33种新的AVPR2突变。本研究描述了在总共117个家庭中观察到的突变多样性、诊断时受影响的人数、严重受影响女性中X染色体失活的偏倚、新发突变的推断亲本来源,并提供了发病率估计。在117个家庭中,有82种不同的假定致病突变。基于单倍型分析,可以推断,当在未知相关的不同家庭中鉴定出相同的AVPR2突变时,这些突变很可能是独立出现的。超过一半的家庭只有一名受影响的男性;两个家庭中有一名严重受影响的女性,且无NDI家族史。在20%的散发病例中,新发突变发生在母亲的卵子发生过程中。加拿大魁北克省X连锁NDI发病率约为每百万男性活产8.8例,这一估计可能代表除新斯科舍省和新不伦瑞克省以外的一般人群,在这两个省份发病率高出六倍多。记录突变的多样性将有助于揭示临床变异的全貌。对X连锁NDI的遗传和群体遗传方面的讨论可能有助于早期诊断和治疗。

相似文献

1
Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.33种新型AVPR2突变报告及117个X连锁肾性尿崩症家系分析
J Am Soc Nephrol. 2000 Jun;11(6):1044-1054. doi: 10.1681/ASN.V1161044.
2
A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.家族性中枢性尿崩症伴 X 连锁遗传性肾性尿崩症女性:病例报告及文献复习。
Am J Med Genet A. 2020 May;182(5):1032-1040. doi: 10.1002/ajmg.a.61516. Epub 2020 Feb 19.
3
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.一种新的AVPR2剪接位点突变导致两兄弟患部分性X连锁肾性尿崩症。
Eur J Pediatr. 2016 May;175(5):727-33. doi: 10.1007/s00431-015-2684-4. Epub 2016 Jan 21.
4
Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus.血管加压素V2受体基因中的六个新突变导致肾性尿崩症。
Nephron. 1997;75(4):431-7. doi: 10.1159/000189581.
5
Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.12个先天性肾性尿崩症家族中血管加压素V2受体和水通道蛋白-2基因的突变
J Am Soc Nephrol. 1997 Dec;8(12):1855-62. doi: 10.1681/ASN.V8121855.
6
Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.女性杂合子血管加压素2型受体突变所致肾性尿崩症的临床表型
Hum Genet. 1995 Jul;96(1):70-8. doi: 10.1007/BF00214189.
7
Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.日本遗传性肾性尿崩症患者:AVPR2 和 AQP2 中 78 个家系的分析及 22 个新突变的报告。
Clin Exp Nephrol. 2013 Jun;17(3):338-44. doi: 10.1007/s10157-012-0726-z. Epub 2012 Nov 14.
8
A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.一个土耳其家族中因AVPR2基因大片段缺失导致严重的肾性尿崩症
Endocrine. 2014 May;46(1):148-53. doi: 10.1007/s12020-013-0043-7. Epub 2013 Sep 13.
9
Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.八个家族中导致肾性尿崩症的分子缺陷的功能特征
J Clin Endocrinol Metab. 2000 Apr;85(4):1703-10. doi: 10.1210/jcem.85.4.6507.
10
Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.28 个中国先天性肾性尿崩症家庭的新型 AVPR2 突变与临床特征。
J Endocrinol Invest. 2021 Dec;44(12):2777-2783. doi: 10.1007/s40618-021-01607-3. Epub 2021 Jun 8.

引用本文的文献

1
A Novel Pathogenic Variant of the Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period.一种自新生儿期起导致抗精氨酸加压素的该基因的新型致病变异。
Genes (Basel). 2025 Aug 21;16(8):989. doi: 10.3390/genes16080989.
2
Construction of arginine vasopressin receptor 2-deficient rats by the rGONAD method.通过rGONAD方法构建精氨酸加压素受体2缺陷型大鼠。
Clin Exp Nephrol. 2025 Mar 18. doi: 10.1007/s10157-025-02652-5.
3
CANDID Study: Clinical and Molecular Characterization of Congenital Arginine Vasopressin-Resistance and the Use of a Novel Diagnostic Biomarker in Indian Children.
CANDID研究:印度儿童先天性精氨酸血管加压素抵抗的临床和分子特征以及一种新型诊断生物标志物的应用
Indian J Pediatr. 2025 Feb 24. doi: 10.1007/s12098-025-05446-5.
4
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).先天性肾性尿崩症(精氨酸加压素抵抗)诊断与管理的国际专家共识声明
Nat Rev Nephrol. 2025 Feb;21(2):83-96. doi: 10.1038/s41581-024-00897-z. Epub 2024 Oct 22.
5
A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic Leukemia: Impact of Steroids on Kidney Function.一例先天性肾性尿崩症伴水通道蛋白 2 基因突变及随后发生急性淋巴细胞白血病:激素对肾功能的影响。
Am J Case Rep. 2024 May 21;25:e943597. doi: 10.12659/AJCR.943597.
6
Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to Nonsense Mutations and Different Clinical Manifestations: A Case Report.3例因无义突变导致先天性肾性尿崩症的儿科患者及不同临床表现:病例报告
Case Rep Nephrol Dial. 2023 Oct 18;13(1):162-172. doi: 10.1159/000533895. eCollection 2023 Jan-Dec.
7
Perioperative Infusion Management for Adhesive Bowel Obstruction with Congenital Nephrogenic Diabetes Insipidus: A Case Report.先天性肾性尿崩症合并粘连性肠梗阻的围手术期输液管理:一例报告
Yonago Acta Med. 2023 May 11;66(2):311-316. doi: 10.33160/yam.2023.05.015. eCollection 2023 May.
8
Congenital nephrogenic diabetes insipidus arginine vasopressin receptor 2 gene mutation at new site: A case report.先天性肾性尿崩症精氨酸加压素受体2基因新位点突变:一例报告
World J Clin Cases. 2022 Dec 26;10(36):13443-13450. doi: 10.12998/wjcc.v10.i36.13443.
9
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones.通过特异性拮抗剂和激动剂药物伴侣对导致V2加压素受体突变的肾性尿崩症进行功能挽救
Front Pharmacol. 2022 Jan 25;13:811836. doi: 10.3389/fphar.2022.811836. eCollection 2022.
10
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner.一种新型的家族性抗利尿激素缺乏性尿崩症,呈 X 连锁隐性遗传方式。
J Clin Endocrinol Metab. 2022 May 17;107(6):e2513-e2522. doi: 10.1210/clinem/dgac076.